[Skip to Content]
[Skip to Content Landing]
Article
May 1982

Staging Laparotomy in Hodgkin's DiseaseMayo Clinic Experience

Author Affiliations

From the Section of Gastroenterologic and General Surgery (Drs Martin, Clark, Beart, and ReMine), Division of Hematology and Internal Medicine (Dr White), and Section of Medical Research Statistics (Mr Ilstrup), Mayo Clinic and Mayo Foundation, Rochester, Minn.

Arch Surg. 1982;117(5):586-591. doi:10.1001/archsurg.1982.01380290048009
Abstract

• Between 1967 and 1979, 316 patients with Hodgkin's disease underwent staging laparotomy. Histologic examination demonstrated lymphocyte predominance in 40(12.7%) patients, nodular sclerosis in 178(56.3%), mixed cellularity in 80(25.3%), and lymphocyte depletion in seven (2.2%); results in 11 (3.5%) patients were considered unclassifiable. There were no deaths. Major complications occurred in 7.9% and required reoperation in 1.9%. Pathologic stage differed from clinical stage in 111 (35.1%) patients. In 90 (28.5%) patients, the stage advanced; in 21 (6.6%) patients, the stage was reduced; and in five (1.6%) patients, the histologic subtype was changed. Stage changes occurred in 40% of those with lymphocyte predominance, in 27.5% with nodular sclerosis, in 46.3% with mixed cellularity, and in 85.7% with lymphocyte depletion. The reliability of staging laparotomy for the determination of appropriate treatment favors its continued use.

(Arch Surg 1982;117:586-591)

×